If Bill Nasgovitz likes these stocks, you should too. This is the last of the Core Fore investing articles.

Commission action on net neutrality is not expected until at least spring 2010, but lobbying efforts among stakeholders are going strong. The council's resolution asks the FCC "to codify strong network neutrality principles in order to ensure that the Internet will continue to foster innovation, increase competition, and spur economic...

See the rest of the story here.

Theflyonthewall.com is Wall Street's specialist in breaking equity news. Veteran traders build a proprietary feed of news that's faster and more relevant than any other source. Try us for free and discover for yourself.

PowerShares DB Crude Oil Short ETN (NYSE: SZO) found its place among ETF gainers today. SZO jumped 3.64% as crude oil fell around 1%.

The Rydex Inverse 2x S&P Select Sector Energy ETF (NYSE: REC) is up 3.39% as Energy sector struggles. REC seeks to reproduce 200% of the inverse performance of the Energy Select Sector Index.

The Claymore/BNY Mellon Frontier Markets ETF (NYSE: FRN) gained 3.15% so far as Emerging market stocks are trading in the positive territory.

ProShares UltraShort MSCI Europe (ETF) (NYSE: EPV) is trading 2.60% up as stocks like Novartis (NYSE: NVS) and BP plc (NYSE: BP) are trading in the red zone. NVS dropped 0.24% and BP lost 1.40%.

Direxion Daily Energy Bear 3X Shs(ETF) (NYSE: ERY) is another ETF that exploited oil weakness today, while Direxion Daily Developed Markets Bear 3x Shs(ETF)
(NYSE: DPK) jumped on the poor performance of the MSCI EAFE Index. ERY is up 2.56% and DPK added 2.38%.

Ultra Short Oil & Gas (NYSE: DUG) added 2.35% as Exxon (NYSE: XOM) and Chevron (NYSE: CVX) fell around 0.3% and 0.5% respectively.

Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=5130601 for the full story.

BloggingStocks: We've put three quarters behind us in 2009, and the most recent one was merely another miserable step downward for the beleaguered newspaper industry. Total ad revenue plummeted in the third quarter to $6.4 billion for the print jockeys, a decline of ... Read more

With a possible buyout of General Electric Co.’s (NYSE: GE) NBC Universal Inc. in the works, Comcast Corp. (Nasdaq: CMCSA) is adapting to a changing technological landscape.[More...]

Consolidated Edison, Inc. (ED), through its subsidiaries, provides electric, gas, and steam utility services in the United States. It provides electric service to approximately 3.3 million customers and gas service to approximately 1.1 million customers in New York City and Westchester County, as well as provides steam service to office buildings, apartment houses, and hospitals in parts of Manhattan.[More...]

The New York City Council is voting on a resolution this morning supporting the idea that Internet service providers cannot discriminate against web traffic on their networks. As gestures go, this resolution supporting net neutrality is more symbolic than it is useful, and to that end has already yielded a couple of photos of FCC [...]

With the heavyweight Novartis (NYSE:NVS) set to commercially launch Fanapt early next year, the schizophrenia drug could quickly gain a foothold in a huge market ($14 billion) that has the lowest selling product raking in over $1 billion in annual sales.

{tiny;TTNP;3}As both long and short term followers of Titan Pharmaceuticals well know, Titan will receive royalties of 8% on Fanapt sales up to $200 million and 10% on all sales thereafter; royalty rates that barely justify the current market cap of the company alone when considering the fact that Novartis, with their push and influence, could make Fanapt an instance force in the schizophrenia market.

And then there is Probuphine. For those new to TTNP, Titan recently received a grant from the NIH to fund a Phase III trial for Probuphine to confirm the drug's effectiveness in treating Opioid addiction.

Probuphine is also being tested in Phase II trials for the treatment of chronic pain.

While I have no doubt that TTNP continues to hold significant potential for the future, I sold a few shares into last week's spike to $2.30 in order to free up some cash and move it around a bit.

With Fanapt ready to launch in a couple of months, the next events that could/should move the TTNP stock price are:

Buyout news. I continue to believe that this is a possibility. Fanapt sales updates by the end of 1Q 2010. Probuphine pipeline updates. Shouldn't come until next year. Partner for probuphine. Could come at anytime, or Titan could go it alone for the time being, using grant money and/or Fanapt royalties. News of a TTNP move to a major exchange, although this only becomes a possibility if no buyout occurs, in my opinion.

In the event that Titan is not acquired, then a stock sale could become a possibility in order for the company to raise funds. If that were to be the case then I would expect it soon after the recent runup.

However, with a Fanapt revenue stream imminent and Probuphine looking more promising with every update, the days of Titan existing solely as a speculative company are dwindling.

Much of this is a rehash for long term readers, and while Titan still has some nice potential moving forward, it's not a bad time for those still holding sub-five cent shares to realize some profits, spread it around, buy wifey a new pair of shoes and take a vacation.

Of course, this is all just my opinion. Do your own DD.

 

Disclosure: Vinny Cassano is Long TTNP.

Companies featured in this segment: AMEC plc (LSE:AMEC), Packaging Corporation of America (NYSE:PKG), BHP Billiton Limited (NYSE:BHP), Rio Tinto plc (NYSE:RTP), Vale SA (NYSE:VALE), ArcelorMittal (NYSE:MT), ThyssenKrupp AG, Adani Power Limited (BSE:533096), Lanco Infratech Power Projects Limited (BSE:532778), Tata Power Company Limited (BSE:500400), Reliance Power Limited (BSE:532939), Vedanta Resources (LSE:VED), Praxair Incorporated (NYSE:PX)